{"id":"https://openalex.org/W1594777461","doi":"https://doi.org/10.1111/ceo.12375","title":"Role of adenosine receptors in resveratrol\u2010induced intraocular pressure lowering in rats with steroid\u2010induced ocular hypertension","display_name":"Role of adenosine receptors in resveratrol\u2010induced intraocular pressure lowering in rats with steroid\u2010induced ocular hypertension","publication_year":2014,"publication_date":"2014-07-04","ids":{"openalex":"https://openalex.org/W1594777461","doi":"https://doi.org/10.1111/ceo.12375","mag":"1594777461","pmid":"https://pubmed.ncbi.nlm.nih.gov/24995479"},"language":"en","primary_location":{"id":"doi:10.1111/ceo.12375","doi":"https://doi.org/10.1111/ceo.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ceo.12375","pdf_url":null,"source":{"id":"https://openalex.org/S95018974","display_name":"Clinical and Experimental Ophthalmology","issn_l":"1442-6404","issn":["1442-6404","1442-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical &amp; Experimental Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078805787","display_name":"Norhafiza Razali","orcid":"https://orcid.org/0000-0002-8439-6713","observed_orcids":["https://orcid.org/0000-0002-8439-6713"]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Norhafiza Razali","raw_affiliation_strings":["Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038092936","display_name":"Renu Agarwal","orcid":"https://orcid.org/0000-0002-3050-7449","observed_orcids":["https://orcid.org/0000-0002-3050-7449"]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Renu Agarwal","raw_affiliation_strings":["Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081925900","display_name":"Puneet Agarwal","orcid":"https://orcid.org/0000-0001-6468-4163","observed_orcids":["https://orcid.org/0000-0001-6468-4163"]},"institutions":[{"id":"https://openalex.org/I62370553","display_name":"IMU University","ror":"https://ror.org/04d4wjw61","country_code":"MY","type":"education","lineage":["https://openalex.org/I62370553"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Puneet Agarwal","raw_affiliation_strings":["Department of Ophthalmology IMU Clinical School International Medical University Seremban Malaysia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology IMU Clinical School International Medical University Seremban Malaysia","institution_ids":["https://openalex.org/I62370553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100722291","display_name":"Sunil Kumar","orcid":"https://orcid.org/0000-0001-9411-3863","observed_orcids":["https://orcid.org/0000-0001-9411-3863"]},"institutions":[{"id":"https://openalex.org/I4210123061","display_name":"National Bureau of Agriculturally Important Microorganisms","ror":"https://ror.org/02pnvb171","country_code":"IN","type":"facility","lineage":["https://openalex.org/I179420787","https://openalex.org/I4210123061"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sunil Kumar","raw_affiliation_strings":["National Bureau of Agriculturally Important Microorganisms (NBAIM) Kushmaur, Kaithauli Mau Nath Bhanjan, \u2010275 101 India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Bureau of Agriculturally Important Microorganisms (NBAIM) Kushmaur, Kaithauli Mau Nath Bhanjan, \u2010275 101 India","institution_ids":["https://openalex.org/I4210123061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110288832","display_name":"Minaketan Tripathy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Minaketan Tripathy","raw_affiliation_strings":["Faculty of Pharmacy; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109256363","display_name":"Sushil Kumar Vasudevan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Sushil Vasudevan","raw_affiliation_strings":["Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110843028","display_name":"Jonathan Guy Crowston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I4210105949","display_name":"Centre for Eye Research Australia","ror":"https://ror.org/01sqdef20","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210105949"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jonathan G Crowston","raw_affiliation_strings":["Centre for Eye Research Australia University of Melbourne Royal Victorian Eye and Ear Hospital East Melbourne Victoria Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Eye Research Australia University of Melbourne Royal Victorian Eye and Ear Hospital East Melbourne Victoria Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I4210105949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102310717","display_name":"Nafeeza Mohd Ismail","orcid":"https://orcid.org/0000-0001-8362-748X","observed_orcids":["https://orcid.org/0000-0001-8362-748X"]},"institutions":[{"id":"https://openalex.org/I4210138650","display_name":"Universiti Teknologi MARA System","ror":"https://ror.org/030847t23","country_code":"MY","type":"education","lineage":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]},{"id":"https://openalex.org/I82724352","display_name":"Universiti Teknologi MARA","ror":"https://ror.org/05n8tts92","country_code":"MY","type":"education","lineage":["https://openalex.org/I82724352"]}],"countries":["MY"],"is_corresponding":false,"raw_author_name":"Nafeeza M Ismail","raw_affiliation_strings":["Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine; Brain and Neuroscience Communities of Research; Universiti Teknologi MARA (UiTM); Shah Alam Selangor","institution_ids":["https://openalex.org/I4210138650","https://openalex.org/I82724352"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":2.8767,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.88821822,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"43","issue":"1","first_page":"54","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trans-resveratrol","display_name":"trans-resveratrol","score":0.9169999957084656},{"id":"https://openalex.org/keywords/adenosine-receptors","display_name":"adenosine receptors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/intraocular-pressure","display_name":"intraocular pressure","score":0.7239999771118164},{"id":"https://openalex.org/keywords/steroid-induced-ocular-hypertension","display_name":"steroid-induced ocular hypertension","score":0.9359999895095825},{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.843999981880188},{"id":"https://openalex.org/keywords/adenosine-a2b-receptor","display_name":"adenosine A2B receptor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/a3-adenosine-receptor","display_name":"A3 adenosine receptor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.6679999828338623},{"id":"https://openalex.org/keywords/protein-ligand-interactions","display_name":"protein-ligand interactions","score":0.9020000100135803},{"id":"https://openalex.org/keywords/topical-drug-delivery","display_name":"topical drug delivery","score":0.5139999985694885},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.8560000061988831}],"concepts":[{"id":"https://openalex.org/C2776816829","wikidata":"https://www.wikidata.org/wiki/Q407329","display_name":"Resveratrol","level":2,"score":0.9705054759979248},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.7458831071853638},{"id":"https://openalex.org/C2781092963","wikidata":"https://www.wikidata.org/wiki/Q650050","display_name":"Intraocular pressure","level":2,"score":0.7393196821212769},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6769793033599854},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.556179940700531},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5558797717094421},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5538514852523804},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.44204625487327576},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.4182998239994049},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3616989254951477},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34599167108535767},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.30072012543678284}],"mesh":[{"descriptor_ui":"D000077185","descriptor_name":"Resveratrol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D007429","descriptor_name":"Intraocular Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009798","descriptor_name":"Ocular Hypertension","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013267","descriptor_name":"Stilbenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014065","descriptor_name":"Tonometry, Ocular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018047","descriptor_name":"Receptors, Purinergic P1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/ceo.12375","doi":"https://doi.org/10.1111/ceo.12375","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ceo.12375","pdf_url":null,"source":{"id":"https://openalex.org/S95018974","display_name":"Clinical and Experimental Ophthalmology","issn_l":"1442-6404","issn":["1442-6404","1442-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical &amp; Experimental Ophthalmology","raw_type":"journal-article"},{"id":"pmid:24995479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24995479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical & experimental ophthalmology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1520269016","display_name":null,"funder_award_id":"600-RMI/RAGS 5/3 (104/2013)","funder_id":"https://openalex.org/F4320321709","funder_display_name":"Ministry of Higher Education, Malaysia"},{"id":"https://openalex.org/G1653450413","display_name":null,"funder_award_id":"600-RMI/RAGS 5/3","funder_id":"https://openalex.org/F4320321709","funder_display_name":"Ministry of Higher Education, Malaysia"},{"id":"https://openalex.org/G414983745","display_name":null,"funder_award_id":"600- RMI/ST/FRGS.5/3/Fst (50/2011","funder_id":"https://openalex.org/F4320321709","funder_display_name":"Ministry of Higher Education, Malaysia"}],"funders":[{"id":"https://openalex.org/F4320321709","display_name":"Ministry of Higher Education, Malaysia","ror":"https://ror.org/05mcs2t73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W127389605","https://openalex.org/W147384863","https://openalex.org/W1957104731","https://openalex.org/W1965554200","https://openalex.org/W1971505749","https://openalex.org/W1973568125","https://openalex.org/W1977870991","https://openalex.org/W1979052674","https://openalex.org/W1986191025","https://openalex.org/W1989228404","https://openalex.org/W1994624502","https://openalex.org/W1996005642","https://openalex.org/W1997013893","https://openalex.org/W2003355068","https://openalex.org/W2017170271","https://openalex.org/W2019574076","https://openalex.org/W2021917695","https://openalex.org/W2031926319","https://openalex.org/W2031933676","https://openalex.org/W2036000851","https://openalex.org/W2048047246","https://openalex.org/W2050456292","https://openalex.org/W2055043387","https://openalex.org/W2065283382","https://openalex.org/W2066458658","https://openalex.org/W2069889108","https://openalex.org/W2079217070","https://openalex.org/W2081912151","https://openalex.org/W2082792223","https://openalex.org/W2083173584","https://openalex.org/W2085681324","https://openalex.org/W2092036055","https://openalex.org/W2106767284","https://openalex.org/W2116049273","https://openalex.org/W2116238347","https://openalex.org/W2120293777","https://openalex.org/W2121953388","https://openalex.org/W2128332459","https://openalex.org/W2128597627","https://openalex.org/W2130479394","https://openalex.org/W2133179696","https://openalex.org/W2134336527","https://openalex.org/W2152638788","https://openalex.org/W2154227202","https://openalex.org/W2171012936","https://openalex.org/W2189525450","https://openalex.org/W2243634106","https://openalex.org/W2442768163"],"related_works":["https://openalex.org/W6980443363","https://openalex.org/W2901091781","https://openalex.org/W2888819398","https://openalex.org/W1813665420","https://openalex.org/W7023408493","https://openalex.org/W3047389850","https://openalex.org/W2031933676","https://openalex.org/W7011836785","https://openalex.org/W127389605","https://openalex.org/W204813013"],"abstract_inverted_index":{"BACKGROUND:":[0],"Steroid-induced":[1],"ocular":[2,39,85,228],"hypertension":[3,40],"is":[4,18,22],"currently":[5],"treated":[6,186,198],"in":[7,35,47,71,81,98,137,184,197,224],"the":[8,16,29,94,125,168,237],"same":[9],"way":[10],"as":[11],"primary":[12],"open-angle":[13],"glaucoma.":[14],"However,":[15],"treatment":[17],"often":[19],"suboptimal":[20],"and":[21,41,120,176,187,210,215],"associated":[23],"with":[24,37,75,83,105,149,164,174,226],"adverse":[25],"effects.":[26],"We":[27],"evaluated":[28],"oculohypotensive":[30,57,169],"effects":[31],"of":[32,43,53,59,63,66,88,96,131,145,161,171],"topical":[33],"trans-resveratrol":[34,67,101,132,150,155,195,204,221],"rats":[36,82,225],"steroid-induced":[38,84,227],"involvement":[42],"adenosine":[44],"receptors":[45],"(AR)":[46],"intraocular":[48],"pressure":[49],"(IOP)":[50],"lowering":[51],"effect":[52,58,77,170],"trans-resveratrol.":[54,172],"METHODS:":[55],"The":[56],"unilateral":[60],"single-drop":[61],"application":[62,196],"various":[64],"concentrations":[65,130],"was":[68,78,90,147,191],"first":[69],"studied":[70,80,91],"oculonormotensive":[72],"rats.":[73],"Concentration":[74],"maximum":[76],"similarly":[79],"hypertension.":[86,229],"Involvement":[87],"AR":[89,106,178],"by":[92,194,213],"observing":[93],"alterations":[95],"IOP":[97,135,143,159,182,223],"response":[99],"to":[100,123],"after":[102],"pretreating":[103],"animals":[104],"subtype-specific":[107],"antagonists.":[108],"Additionally,":[109],"we":[110],"used":[111],"computational":[112],"methods,":[113],"including":[114],"3D":[115,117],"modelling,":[116],"structure":[118],"generation":[119],"protein-ligand":[121],"interaction,":[122],"determine":[124],"AR-trans-resveratrol":[126],"interaction.":[127],"RESULTS:":[128],"All":[129],"produced":[133,157,180],"significant":[134,181],"reduction":[136,144,160,183],"normotensive":[138],"rat":[139],"eyes.":[140,199],"Maximum":[141],"mean":[142],"15.1%":[146],"achieved":[148],"0.2%.":[151],"In":[152],"oculohypertensive":[153],"rats,":[154],"0.2%":[156],"peak":[158],"25.2%.":[162],"Pretreatment":[163,173],"A\u2081":[165,238],"antagonist":[166],"abolished":[167],"A\u2083":[175,216],"A\u2082A":[177],"antagonists":[179],"both":[185],"control":[188],"eyes,":[189],"which":[190],"further":[192],"augmented":[193],"Computational":[200],"studies":[201],"showed":[202],"that":[203],"has":[205],"highest":[206],"affinity":[207],"for":[208],"A\u2082B":[209],"A\u2081,":[211],"followed":[212],"A2A":[214],"AR.":[217,239],"CONCLUSION:":[218],"Topically":[219],"applied":[220],"reduces":[222],"Trans-resveratrol-induced":[230],"oculohypotension":[231],"involves":[232],"its":[233],"agonistic":[234],"activity":[235],"at":[236]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
